Practical dietary advices for subjects with alpha-1 antitrypsin deficiency

Biomed Pharmacother. 2023 Jul:163:114753. doi: 10.1016/j.biopha.2023.114753. Epub 2023 Apr 27.

Abstract

Congenital alpha-1 antitrypsin deficiency (AATD) is a rare inherited disorder caused by the mutation of the SERPINA1 gene on chromosome 14. At pulmonary level, AAT deficiency leads to an increased risk of chronic obstructive pulmonary disease (COPD) and emphysema, starting from the third-fourth decade of life. At hepatic level, some variants of the allelic, in particular PI*Z, cause a conformational change of the AAT molecule, which polymerizes within the hepatocytes. Excessive hepatic accumulation of these abnormal molecules can lead to liver disease in both adults and children, with clinical presentation ranging from cholestatic jaundice in the newborn to abnormal blood indices of liver function in children and adults, up to fatty liver, cirrhosis and hepatocarcinoma. Nutritional interventions in AATD aim to provide the necessary calories, stop protein catabolism, prevent and treat malnutrition as in the case of common COPD, and even take into account any liver disease that is a distinctive trait, compared to common COPD. Actually, there is a lack of formal research regarding the effects of specific nutritional recommendations in patients with AATD, proper eating habits may help to preserve lung and liver function. For practical dietary advice in patients with AATD and COPD, recently a food pyramid proposal has been published. It has been observed that there is a marked overlap between AATD liver disease and obesity-related liver disease, suggesting shared molecular basis and, therefore, similar nutritional strategies. In this narrative review dietary advice for all possible stages of liver disease have been reported.

Keywords: Alpha-1 antitrypsin deficiency; Chronic obstructive pulmonary disease; Dietary advice.

Publication types

  • Review

MeSH terms

  • Adult
  • Child
  • Humans
  • Infant, Newborn
  • Lung
  • Pulmonary Disease, Chronic Obstructive* / etiology
  • Pulmonary Emphysema*
  • alpha 1-Antitrypsin / genetics
  • alpha 1-Antitrypsin / metabolism
  • alpha 1-Antitrypsin Deficiency* / drug therapy
  • alpha 1-Antitrypsin Deficiency* / genetics

Substances

  • alpha 1-Antitrypsin